secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2022-06-07T23:59:59+00:00
Accession:  0001193125-22-169367
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte annual meeting: directors re-elected, say-on-pay approved, auditor ratified
--------------------------------------------------------------------------------

- Peter Hirth re-elected as Class II director with 44,840,461 votes for, 2,557,604 withheld.
- Heath Lukatch re-elected as Class II director with 44,945,210 votes for, 2,452,855 withheld.
- Say-on-pay proposal passed with 47,263,430 for, 132,867 against, 1,768 abstentions.
- Future say-on-pay frequency set at one year based on 47,358,585 votes for one year.
- Deloitte & Touche LLP ratified as auditor for FY2022 with 51,800,260 for, 335 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522169367/0001193125-22-169367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522169367/d318726d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-169367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer